Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
CRADA covers global health challenges
January 13, 2012
By: Tim Wright
FEI has entered into a Cooperative Research And Development Agreement (CRADA) with the National Institutes of Health (NIH), creating a “Living Lab Structural Biology Center” that integrates cryo-electron microscopy (EM), nuclear magnetic resonance (NMR) spectroscopy, and X-ray diffraction (XRD), aimed at accelerating discoveries for global health challenges such as HIV/AIDS and cancer. The lab will be located on the NIH campus, and represents an interdisciplinary collaboration among experts from FEI and the National Cancer Institute (NCI) and the National Institute of Diabetes and Digestive and Kidney Diseases. The research program will utilize FEI’s Titan Krios transmission electron microscope (TEM), among the world’s most powerful commercially-available electron microscopes for structural biology, and continued development of other state-of-the-art technologies to advance the scientific scope of the collaboration. Dr. Sriram Subramaniam, senior investigator in the Laboratory of Cell Biology of the NCI, and a recognized leader in cryo-electron microscopy and related techniques, will serve as director of the Living Lab. Leading NIH scientists in various other fields, including NMR spectroscopists such as Drs. Adriaan Bax and G. Marius Clore, X-ray crystallographers such as Drs. Fred Dyda and Alex Wlodawer and biochemists such as Drs. Suresh Ambudkar and Stuart Le Grice, will also actively participate in the research program. FEI’s president and chief executive officer, Dr. Don Kania said, “This collaborative effort with NIH is a critical part of our strategy to provide complete microscopy solutions for life science research. Our Life Sciences business has been increasing rapidly and is a key part of our overall corporate growth plan. Helping our customers obtain increased value from electron microscopy in conjunction with and complementary to XRD and NMR is a key element of that plan.”
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !